Roberta Ruda

Summary

Publications

  1. pmc Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study
    Roberta Ruda
    Corresponding Author Roberta Rudà, MD, Department of Neuro Oncology, Via Cherasco 15, 10126 Torino, Italy
    Neuro Oncol 15:1739-49. 2013
  2. pmc Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments
    Roberta Ruda
    Department of Neuro Oncology, University of Turin and San Giovanni Battista Hospital, Turin, Italy
    Neuro Oncol 14:iv55-64. 2012
  3. doi request reprint Epilepsy and brain tumors
    Roberta Ruda
    Division of Neuro Oncology, Department of Neuroscience, San Giovanni Battista Hospital and University of Torino, Torino, Italy
    Curr Opin Oncol 22:611-20. 2010
  4. ncbi request reprint New chemotherapy options for the treatment of malignant gliomas
    Riccardo Soffietti
    Division of Neuro Oncology, Departments of Neuroscience and Oncology, University and San Giovanni Battista Hospital, Turin, Italy
    Anticancer Drugs 18:621-32. 2007
  5. ncbi request reprint New developments in the treatment of malignant gliomas
    Riccardo Soffietti
    University and San Giovanni Battista Hospital, Division of Neuro Oncology, Department of Neuroscience, Turin, Italy
    Expert Rev Neurother 7:1313-26. 2007
  6. doi request reprint Brain metastases: current management and new developments
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience and Oncology, University and San Giovanni Battista Hospital, Turin, Italy
    Curr Opin Oncol 20:676-84. 2008
  7. doi request reprint Targeted therapy in brain metastasis
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Torino, Italy
    Curr Opin Oncol 24:679-86. 2012
  8. doi request reprint Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Riccardo Soffietti
    Dept Neuro Oncology, University and City of Health and Science Hospital of Turin, Via Cherasco 15, 10126, Turin, Italy
    J Neurooncol 116:533-41. 2014
  9. ncbi request reprint Neuro-oncology: new insights and advances in treatment
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Torino, Italy
    Lancet Neurol 7:14-6. 2008
  10. ncbi request reprint Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study
    Riccardo Soffietti
    Neuro Oncology Service, Department of Neuroscience, San Giovanni Battista Hospital, University of Turin, Turin, Italy
    Cancer 100:807-13. 2004

Collaborators

Detail Information

Publications14

  1. pmc Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study
    Roberta Ruda
    Corresponding Author Roberta Rudà, MD, Department of Neuro Oncology, Via Cherasco 15, 10126 Torino, Italy
    Neuro Oncol 15:1739-49. 2013
    ..Little information is available regarding the effect of conventional radiotherapy on glioma-related seizures...
  2. pmc Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments
    Roberta Ruda
    Department of Neuro Oncology, University of Turin and San Giovanni Battista Hospital, Turin, Italy
    Neuro Oncol 14:iv55-64. 2012
    ..Newer AEDs (levetiracetam, topiramate, lacosamide) seem to be better tolerated than the old AEDs (phenobarbital, phenytoin, carbamazepine), but there is lack of evidence regarding their superiority in terms of efficacy...
  3. doi request reprint Epilepsy and brain tumors
    Roberta Ruda
    Division of Neuro Oncology, Department of Neuroscience, San Giovanni Battista Hospital and University of Torino, Torino, Italy
    Curr Opin Oncol 22:611-20. 2010
    ..To present an overview of the recent findings in pathophysiology and management of epileptic seizures in patients with brain tumors...
  4. ncbi request reprint New chemotherapy options for the treatment of malignant gliomas
    Riccardo Soffietti
    Division of Neuro Oncology, Departments of Neuroscience and Oncology, University and San Giovanni Battista Hospital, Turin, Italy
    Anticancer Drugs 18:621-32. 2007
    ....
  5. ncbi request reprint New developments in the treatment of malignant gliomas
    Riccardo Soffietti
    University and San Giovanni Battista Hospital, Division of Neuro Oncology, Department of Neuroscience, Turin, Italy
    Expert Rev Neurother 7:1313-26. 2007
    ....
  6. doi request reprint Brain metastases: current management and new developments
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience and Oncology, University and San Giovanni Battista Hospital, Turin, Italy
    Curr Opin Oncol 20:676-84. 2008
    ..To review the state-of-the-art and new developments in the management of patients with brain metastases...
  7. doi request reprint Targeted therapy in brain metastasis
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Torino, Italy
    Curr Opin Oncol 24:679-86. 2012
    ..To review the state of the art and new developments in the field of targeted agents for brain metastases...
  8. doi request reprint Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Riccardo Soffietti
    Dept Neuro Oncology, University and City of Health and Science Hospital of Turin, Via Cherasco 15, 10126, Turin, Italy
    J Neurooncol 116:533-41. 2014
    ..Future studies should explore alternative regimens of combination of the two drugs. ..
  9. ncbi request reprint Neuro-oncology: new insights and advances in treatment
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Torino, Italy
    Lancet Neurol 7:14-6. 2008
  10. ncbi request reprint Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study
    Riccardo Soffietti
    Neuro Oncology Service, Department of Neuroscience, San Giovanni Battista Hospital, University of Turin, Turin, Italy
    Cancer 100:807-13. 2004
    ..In the current study, the authors investigated the use of carboplatin as a second-line chemotherapeutic agent against these types of tumors...
  11. doi request reprint What have we learned from trials on antiangiogenic agents in glioblastoma?
    Riccardo Soffietti
    Department of Neuro Oncology, University and City of Health and Science Hospital of Turin, Turin, Italy
    Expert Rev Neurother 14:1-3. 2014
    ..The Phase III CENTRIC trial has excluded any role for cilengitide in addiction to standard treatment in newly diagnosed glioblastoma. ..
  12. doi request reprint Neurologic complications of chemotherapy and other newer and experimental approaches
    Riccardo Soffietti
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy Electronic address
    Handb Clin Neurol 121:1199-218. 2014
    ..Last, the so-called "chemobrain" is an emerging issue, as it is a model of a subtle of and long-lasting damage to neuronal structures from some antineoplastic agents. ..
  13. ncbi request reprint Management of brain metastases
    Riccardo Soffietti
    II Division of Neurology, Dept Neuroscience, University and San Giovanni Battista, Hospital, V Cherasco 15, 10126, Torino, Italy
    J Neurol 249:1357-69. 2002
    ..New radiosensitizers and cytotoxic or cytostatic agents, and innovative technique of drug delivery are being investigated...
  14. doi request reprint Ependymomas of the adult: molecular biology and treatment
    Roberta Ruda
    Division of Neuro Oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy
    Curr Opin Neurol 21:754-61. 2008
    ..To review state of art and relevant advances in the molecular biology and management of ependymomas of the adult...